Cargando…
Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
BACKGROUND: The majority of colorectal carcinomas (CRCs) are insensitive to programmed death protein-1/programmed death-ligand 1 (anti-PD-1/PD-L1) immune checkpoint inhibitor (ICI) antibodies. While there are many causes for ICI insensitivity, recent studies suggest that suppression of innate immune...
Autores principales: | Hwang, Bin-Jin, Tsao, Li-Chung, Acharya, Chaitanya R, Trotter, Timothy, Agarwal, Pankaj, Wei, Junping, Wang, Tao, Yang, Xiao-Yi, Lei, Gangjun, Osada, Takuya, Lyerly, Herbert Kim, Morse, Michael A, Hartman, Zachary Conrad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971789/ https://www.ncbi.nlm.nih.gov/pubmed/35361727 http://dx.doi.org/10.1136/jitc-2021-003721 |
Ejemplares similares
-
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
por: Mao, Chenkai, et al.
Publicado: (2022) -
Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors
por: Reil, Katherine A, et al.
Publicado: (2023) -
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer
por: Lee, Yu Seong, et al.
Publicado: (2020) -
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
por: Allouchery, Marion, et al.
Publicado: (2020) -
Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity
por: Taki, Shunichi, et al.
Publicado: (2021)